Virginia Medicaid and State Employee Coverage
Cardinal Care and the COVA plans have Virginia’s strictest weight-loss medication rules — and both changed on July 1, 2026.
New here? Start with the coverage overview to understand the two gates and the diagnosis backdoor before reading the plan rules below.
Virginia Medicaid (Cardinal Care)
Virginia Medicaid covers these drugs, but with the strictest criteria of any major payer in the state. The rules below come from the Commonwealth’s official Weight-Loss Management authorization form, effective July 1, 2026, and apply to fee-for-service members and to managed care plans including Anthem HealthKeepers Plus, Aetna Better Health, Molina, Sentara Community Plan, and UnitedHealthcare Community Plan.
For Zepbound, Wegovy, and Saxenda, you must have:
- BMI over 40, or BMI over 37 with high cholesterol, high blood pressure, or type 2 diabetes; and
- Tried and failed a non-GLP-1 weight-loss medication, or be intolerant to all of them; and
- Tried and failed the plan’s preferred product first, per the Preferred Drug List; and
- Not be taking another GLP-1 at the same time
A “failed trial” is specifically defined. For older weight-loss drugs like phentermine, that means three months without losing 10 pounds. For orlistat, six months without losing 10 pounds. For a GLP-1, six months without a 5% body-weight reduction.
Additional requirements. Your provider must attest in writing that your obesity is “disabling and life threatening.” You must be participating in nutritional counseling and a physical activity program. Your chart must include a weight-loss plan and accurate height and weight measurements from within the last 60 days.
Age minimums. Wegovy and Saxenda injections from age 12; Wegovy HD, Wegovy tablets, and Zepbound from age 18.
How long approvals last. GLP-1 approvals run six months at a time. Renewal requires at least 5% weight loss compared with your most recent authorization and must be submitted within 30 days of expiration. Renewals stop once a member’s BMI falls below 25.
Oral GLP-1s face an extra hurdle. For a GLP-1 pill, you must also document a medical reason you can’t use an injection, or show that two injectable products failed.
Virginia state employee plans (COVA Care, COVA HealthAware, COVA HDHP)
This changed on July 1, 2026, and the change was significant.
Virginia’s state employee health plan now requires a BMI of 35 or higher for weight-loss GLP-1 coverage — up from the previous 27/30 standard. The Department of Human Resource Management states it directly: “A Body Mass Index (BMI) of 35 or higher is required to obtain a weight loss GLP-1 medication.”
Current users are not grandfathered. Existing patients become subject to the new BMI criteria once their current prior authorization expires.
Why it happened. In an April 2026 presentation to the Senate Finance and Appropriations Committee, DHRM reported that GLP-1 spending had grown from $30 million to $200 million, with Wegovy the plan’s single largest drug expense at $47 million and Zepbound third at $34 million. Raising the BMI threshold was adopted as a cost-containment measure, described in plan documents as “similar to Medicaid.”
What you’ll pay. GLP-1s prescribed for weight loss sit on Tier 3 for COVA Care — a $45 copay for up to a 34-day supply — and are not treated as specialty drugs. A new $150/$300 pharmacy deductible now applies to Tier 2, 3, and 4 drugs, so your first fill of the plan year will cost more. COVA HealthAware and COVA HDHP members pay 20% coinsurance after their deductible. The plan also moved to the National Direct Preferred formulary on July 1, 2026, which may change which specific products are preferred.
If you no longer meet the new BMI threshold
The diagnosis backdoor matters most here. Sleep apnea, type 2 diabetes, established cardiovascular disease, and MASH liver disease are governed by different criteria than weight-loss coverage — see the overview. If nothing applies, review denials and cash-pay pricing, or consider surgical options, which most Virginia plans still cover.
Frequently asked questions
What BMI does Virginia Medicaid require for weight-loss medication?
Virginia Medicaid (Cardinal Care) has the strictest criteria of any major payer in the state: BMI over 40, or BMI over 37 with high cholesterol, high blood pressure, or type 2 diabetes. You must also have tried and failed a non-GLP-1 weight-loss medication and the plan's preferred product, and your provider must attest that your obesity is disabling and life threatening.
Did Virginia state employee coverage change?
Yes. Effective July 1, 2026, the Virginia state employee plans (COVA) require a BMI of 35 or higher for weight-loss GLP-1 coverage, up from the previous 27/30 standard. Current users are not grandfathered — existing patients become subject to the new criteria once their prior authorization expires.
Other coverage guides
Not sure where you stand?
Our team helps patients verify benefits and submit prior authorizations every day. Start with a consultation and we’ll work through your plan’s requirements together.